Reimbursement & Directory Validation Update

Reimbursement Change
Effective Oct. 1, BCBSWY will begin using J-code level pricing for J-1745 (infliximab). We will no longer be pricing this medication at the NDC code level. Reimbursement will be at the biosimilar rate.

Directory Validation Tip
In Availity, beneath the user account, please select “Manage My Organization” to make updates. (See screenshot below.) Additional instructions are located here to help you find NPI and tax ID combinations. This helps facilitate compliance with the No Surprises Act (NSA) provider directory validation requirements. The NSA requires you confirm this information with us every 90 days, so your information can continue to be listed in our public directory.

Share

Related Posts
provider-news
Online Prior Authorization Webinar
We appreciate those who were able to attend our one-hour Prior Authorization training. We hope that the webinar was helpful. We covered many topics;…
Online Prior Authorization Updates II
We will soon send an invite for a brief one-hour Prior Authorization training. Please monitor your email if you would like to attend this…
Online Prior Authorization Updates
We are actively working to correct a system issue with online authorizations displaying the incorrect effective and expiration date of an authorization. This is…

Fewer Hassles. Better Service.